<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_Freiburg_Parts skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:Freiburg/Parts</SPAN></H1><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><P><TITLE>&quot;&quot;</TITLE></P><DIV id="header"><DIV id="naviconwrapper"><DIV id="naviconbar"><DIV id="navicons"><UL><LI id="home"><A href="https://2015.igem.org/Team:Freiburg/Home">Home</A></LI><LI id="project"><A href="https://2015.igem.org/Team:Freiburg/Project/Overview">Project</A></LI><LI id="team"><A href="https://2015.igem.org/Team:Freiburg/Team">Team</A></LI><LI id="results"><A href="https://2015.igem.org/Team:Freiburg/Results">Results</A></LI><LI id="policy" style="font-size:11px"><A href="https://2015.igem.org/Team:Freiburg/Practices">Human Practice</A></LI><LI id="notebook"><A href="https://2015.igem.org/Team:Freiburg/Notebook">Notebook</A></LI></UL></DIV></DIV></DIV><DIV id="navtextwrapper"><DIV id="navtext"><UL id="project-sub"><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/Project/Overview">Introduction</A></LI><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/Project/System">Overview</A></LI><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/Design">Diagnostics today</A></LI><LI><A class="navsub1 subsubmenu" href="#">The DiaCHIP</A></LI><LI><A class="navsub2" href="https://2015.igem.org/Team:Freiburg/Project/DNA_Engineering">DNA Engineering</A></LI><LI><A class="navsub2" href="https://2015.igem.org/Team:Freiburg/Project/Cellfree_Expression">Cell-Free Expression</A></LI><LI><A class="navsub2" href="https://2015.igem.org/Team:Freiburg/Project/Protein_Purification">Protein Purification</A></LI><LI><A class="navsub2" href="https://2015.igem.org/Team:Freiburg/Project/Surface_Chemistry">Surface Chemistry</A></LI><LI><A class="navsub2" href="https://2015.igem.org/Team:Freiburg/Project/iRIf">Optical Detection</A></LI></UL><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/Project/Future_Directions">Outlook</A></LI><UL id="team-sub"><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/Team">Members</A></LI><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/Attributions">Acknowledgements</A></LI><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/Partners">Partners</A></LI></UL><UL id="results-sub"><LI><A class="navsub1 subsubmenu" href="#">The DiaCHIP</A></LI><LI><A class="navsub2" href="https://2015.igem.org/Team:Freiburg/Results">Main Results</A></LI><LI><A class="navsub2" href="https://2015.igem.org/Team:Freiburg/Results/Diagnostics">Diagnostics</A></LI><LI><A class="navsub2" href="https://2015.igem.org/Team:Freiburg/Results/Own_Device">Our Device</A></LI><LI><A class="navsub2" href="https://2015.igem.org/Team:Freiburg/Results/Immobilization">DNA Array</A></LI><LI><A class="navsub2" href="https://2015.igem.org/Team:Freiburg/Results/Cellfree">Cell-Free Expression</A></LI><LI><A class="navsub2" href="https://2015.igem.org/Team:Freiburg/Results/Surface">Binding on Surface</A></LI><LI><A class="navsub2" href="https://2015.igem.org/Team:Freiburg/Results/Modeling">Modeling</A></LI></UL><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/Parts">BioBricks</A></LI><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/Collaborations">Collaborations</A></LI><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/InterLab_Study">Interlab Study</A></LI><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/Achievements">Achievements</A></LI><UL id="policy-sub"><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/Human_Practice/Science_Fair">Science Fair</A></LI><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/Human_Practice/Theater_Project">Theater Project</A></LI><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/Human_Practice/Public_Opinion">Public Opinion</A></LI><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/Human_Practice/College">College Talk</A></LI><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/Human_Practice/Ethics">Ethics</A></LI></UL><UL id="notebook-sub"><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/Labjournals">Labjournals</A></LI><LI><A class="navsub1 subsubmenu" href="#">Techniques</A></LI><LI><A class="navsub2" href="https://2015.igem.org/Team:Freiburg/Project/Classic_vs_Gibson">Gibson</A></LI><LI><A class="navsub2" href="https://2015.igem.org/Team:Freiburg/Project/Coli_Strains">E.coli Strains</A></LI></UL><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/Protocols">Protocols</A></LI><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/Materials">Materials</A></LI><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/Safety">Safety</A></LI><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/Wikimigration">Wiki-Tricks</A></LI><LI><A class="navsub1" href="https://2015.igem.org/Team:Freiburg/Glossary">Glossary</A></LI></DIV></DIV></DIV><DIV class="clearfix" id="smallnav"><UL class="clearfix"><LI id="home_small"><A href="https://2015.igem.org/Team:Freiburg/Home">Home</A></LI><LI id="project_small"><A href="https://2015.igem.org/Team:Freiburg/Project/Overview">Project</A></LI><LI id="results_small"><A href="https://2015.igem.org/Team:Freiburg/Results">Results</A></LI><LI id="team_small"><A href="https://2015.igem.org/Team:Freiburg/Team">Team</A></LI><LI id="policy_small"><A href="https://2015.igem.org/Team:Freiburg/Practices">Practice</A></LI><LI id="notebook_small"><A href="https://2015.igem.org/Team:Freiburg/Notebook">Notebook</A></LI></UL><A href="#" id="pull">Menu</A></DIV><DIV class="content_background_wrapper"><DIV class="central_position_wrap"><DIV id="bubble_wrapper"><DIV id="bubble_sidebar" class="bubble2"><P><A id="bubble2" href="#firstHeading">text</A></P></DIV><DIV id="bubble_sidebar" class="bubble3"><P><A id="bubble3" href="">next</A></P></DIV></DIV><DIV class="page_content"><DIV class="content_box"><H1 class="sectionedit1">BioBricks</H1><DIV class="level1"><P> 
Our project involved the expression of many antigenic peptides. Their immunodominant properties make them feasible for many medical purposes. As ‘Health and Medicine’ is one of the most popular tracks chosen by iGEM Teams, we want to share the sequences encoding for these peptides with the iGEM Community. Thus, future iGEM Teams have the opportunity to take advantage of our research if they are planning to work in the field of diagnostics.

Most of the sequences were obtained by paper research and have been synthesized by <A class="media" href="https://eu.idtdna.com/site" target="_blank" title="IDT">Integrated DNA technologies</A>, engaging their special offer for iGEM Teams. Before ordering, we used the IDT codon optimization tool to optimize the sequences for efficient expression in <I>E. coli</I>. Planning to submit the sequences to the Registry, recognition sites for restriction enzymes used for standard cloning have been removed without causing amino acid changes. 

The group of Prof. Dr. Stefan Dübel (TU Braunschweig) provided us with an <A href="http://parts.igem.org/Part:BBa_K1621006" target="_blank">antigen specific for <I>Salmonella</I> Typhimurium</A> and a corresponding single chain variable fragment (scFv). They generated the scFv themselves after identifying the immunodominant properties of the protein. Thanks to their work we are able to provide the Registry with a specific pair of antigen and scFv.

All our BioBricks are summarized in the table below. Additionally, the table guides you to more detailed info pages as well as to the corresponding Registry pages.
</P><P>
Although these parts significantly expand the <A class="media" href="http://parts.igem.org/Main_Page" target="_blank" title="Registry">Registry</A> in terms of diagnostics, none of them is our favorite BioBrick. To reach the high yields of protein expression we needed for our project we used a commercial vector optimized for inducible protein overexpression. This was unavoidable as inserting the required parts (like the lacI gene or a lacI repressible promoter) into pSB1C3 did not result in satisfying protein amounts. Most likely these problems were due to the high-copy origin of replication wasting a lot of metabolic capacity on unnecessary replication. 
So far, the only plasmid backbone in the Registry with a low-copy origin of replication is <A class="urlextern" href="http://parts.igem.org/Part:pSB6A1" rel="nofollow" target="_Blank" title="http://parts.igem.org/Part:pSB6A1">pSB6A1</A>.

</P><P>
Therefore, we developed an improved version of this plasmid backbone by combining it with a commercial expression vector. Uniting features required for efficient protein overexpression and elements related to iGEM standard cloning, we enable future iGEM Teams to perform highly productive protein overexpression based on our new backbone. 

Working <I>in vitro</I> is an upcoming issue in synthetic biology. The rapid development of chemical methods for gene or RNA synthesis are only examples emphasizing the importance of <I>in vitro</I> experiments. On the other side, the variety of methods for <I>in vitro</I> protein production is rather small<SUP><A class="fn_top" href="#fn__1" id="fnt__1" name="fnt__1">1)</A></SUP> making conventional protein expression and purification still an essential method. Therefore, pOP, the <STRONG>p</STRONG>lasmid for <STRONG>O</STRONG>verexpression of <STRONG>P</STRONG>roteins, is our favorite BioBrick. 
</P><P>
Find out more about the <A href="https://2015.igem.org/Team:Freiburg/Description">pOP vector </A>and check if it also meets your requirements!
</P><DIV class="table sectionedit2"><TABLE class="inline"><TBODY><TR class="row0"><TH class="col1 leftalign"> BioBrick  </TH><TH class="col1 leftalign"> short description  </TH><TH class="col0 centeralign"> detailed desription  </TH></TR><TR class="row1"><TD class="col1"><A class="urlextern" href="http://parts.igem.org/Part:BBa_K1621009" rel="nofollow" target="_Blank" title="http://parts.igem.org/Part:BBa_K1621009">BBa_K1621009</A></TD><TD class="col0"> Standardized plasmid backbone optimized for protein overexpression</TD><TD class="col0"><A class="wikilink1" href="https://2015.igem.org/Team:Freiburg/Description" title="pop_-_protein_expression_meets_igem_standards">pOP</A></TD></TR><TR class="row2"><TD class="col1"><A class="urlextern" href="http://parts.igem.org/Part:BBa_K1621006" rel="nofollow" target="_Blank" title="http://parts.igem.org/Part:BBa_K1621006">BBa_K1621006</A></TD><TD class="col0"><I> Salmonella</I> Typhimurium specific antigenic protein (DHAD)</TD><TD class="col0"><A class="wikilink1" href="https://2015.igem.org/Team:Freiburg/Project/pRIG15_15" title="prig15_15">pRIG15_15</A></TD></TR><TR class="row3"><TD class="col1"><A class="urlextern" href="http://parts.igem.org/Part:BBa_K1621005" rel="nofollow" target="_Blank" title="http://parts.igem.org/Part:BBa_K1621005">BBa_K1621005</A></TD><TD class="col0"><I> Treponema pallidum</I> specific antigenic peptides derived from bacterioferritin (TpF1)</TD><TD class="col0"><A class="wikilink1" href="https://2015.igem.org/Team:Freiburg/Project/pRIG15_18" title="prig15_18">pRIG15_18</A></TD></TR><TR class="row4"><TD class="col1"><A class="urlextern" href="http://parts.igem.org/Part:BBa_K1621004" rel="nofollow" target="_Blank" title="http://parts.igem.org/Part:BBa_K1621004">BBa_K1621004</A></TD><TD class="col0"> Human Immunodeficiency Virus specific antigenic epitopes derived from a polyprotein called gag/tat/pol/env</TD><TD class="col0"><A class="wikilink1" href="https://2015.igem.org/Team:Freiburg/Project/pRIG15_17" title="prig15_17">pRIG15_17</A></TD></TR><TR class="row5"><TD class="col1"><A class="urlextern" href="http://parts.igem.org/Part:BBa_K1621003" rel="nofollow" target="_Blank" title="http://parts.igem.org/Part:BBa_K1621003">BBa_K1621003</A></TD><TD class="col0"><I> Clostridium tetani</I> specific antigenic epitopes derived from tetanus neurotoxin (TeNT_Hc)</TD><TD class="col0"><A class="wikilink1" href="https://2015.igem.org/Team:Freiburg/Project/pRIG15_11" title="prig15_11">pRIG15_11</A></TD></TR><TR class="row6"><TD class="col1"><A class="urlextern" href="http://parts.igem.org/Part:BBa_K1621002" rel="nofollow" target="_Blank" title="http://parts.igem.org/Part:BBa_K1621002">BBA_K1621002</A></TD><TD class="col0"> Herpes Simplex specific antigenic epitopes derived from glycoprotein G</TD><TD class="col0"><A class="wikilink1" href="https://2015.igem.org/Team:Freiburg/Project/pRIG15_8" title="prig15_8">pRIG15_8</A></TD></TR><TR class="row7"><TD class="col1"><A class="urlextern" href="http://parts.igem.org/Part:BBa_K1621001" rel="nofollow" target="_Blank" title="http://parts.igem.org/Part:BBa_K1621001">BBa_K1621001</A></TD><TD class="col0"> Varicella Zoster Virus specific antigenic epitopes derived from glycoprotein E</TD><TD class="col0"><A class="wikilink1" href="https://2015.igem.org/Team:Freiburg/Project/pRIG15_7" title="prig15_7">pRIG15_7</A></TD></TR><TR class="row8"><TD class="col1"><A class="urlextern" href="http://parts.igem.org/Part:BBa_K1621000" rel="nofollow" target="_Blank" title="http://parts.igem.org/Part:BBa_K1621000">BBa_K1621000</A></TD><TD class="col0"> Rubella Virus specific antigenic epitopes derived from glycoprotein E1</TD><TD class="col0"><A class="wikilink1" href="https://2015.igem.org/Team:Freiburg/Project/pRIG15_6" title="pRIG15_6">pRIG15_6</A></TD></TR></TBODY></TABLE></DIV><DIV class="footnotes"><DIV class="fn"><SUP><A class="fn_bot" href="#fnt__1" id="fn__1" name="fn__1">1)</A></SUP><A class="urlextern" href="http://genome.cshlp.org/content/17/1/1.full" rel="nofollow" target="_Blank" title="http://genome.cshlp.org/content/17/1/1.full">Forster and Church, 2015. Genome Research.</A></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></BODY></HTML>